Living in Washington, D.C. means I am fortunate to be close to a lot of interesting moments in American History. This past Monday was no exception. Monday, April 15th, the oral arguments were held for the Association of Molecular Pathology (lead by the ACLU) vs. Myriad Genetics. The hearing challenged some of Myriad's patents related … Continue reading I was there: The Supreme Court Oral Arguments on Gene Patents.
Musings of an ex-pharma rep.
I'm hesitant to post this one. Today many of my hardworking, dedicated former colleagues at Lilly will find out they no longer have a job. I believe some of this could have been avoided. To Lilly's credit, it has made tremendous efforts to keep as many sales people as it could over the years while … Continue reading Musings of an ex-pharma rep.
New hope in HER-2 Positive Metastatic Breast Cancer
Last week marked a very exciting moment for anyone with any involvement in breast cancer patient care, including, and especially, for breast cancer patients. On February 22 2013, the FDA approved Kadcyla, a new treatment for HER-2 positive metastatic breast cancer. Kadcyla was formerly known to many in the cancer world as T-DM1 and has … Continue reading New hope in HER-2 Positive Metastatic Breast Cancer
Medicine X: The Future of Health Care Delivery.
I think I may have just found the coolest most forward thinking medical conference, ever: Stanford's Medicine X conference. If you are not familiar, here's a very small preview of what this conference is all about: "Medicine X is about the future of medicine and health care. It is about how social media and information … Continue reading Medicine X: The Future of Health Care Delivery.